Clinical Trial Update: A Study of Trastuzumab Emtansine in Indian Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced or Metastatic Breast Cancer Who Have Received Prior Treatment With Trastuzumab and a Taxane [Phase 4]

View source ↗

Summary

Phase 4 trial of trastuzumab emtansine in Indian patients with HER2-positive unresectable locally advanced or metastatic breast cancer who previously received t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Trastuzumab emtansine (ado-trastuzumab emtansine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: HER2 Positive Breast Cancer, Metastatic Breast Cancer, Locally Advanced Breast Cancer | Phase 4 | Status: COMPLETED | Results posted: 2021-02-09